Acelot is a development stage biopharmaceutical company focused on therapies for neurodegenerative disorders.
Our novel machine learning and in vitro assay platform identifies small molecules that act specifically upon toxic forms of proteins found in neurodegenerative diseases.
Kevin Burk
Data Scientist, MS
Software and machine learning expert